News
ICCM
3.105
-11.54%
-0.405
Icecure Medical Q2 EPS $(1.37) Beats $(1.40) Estimate, Sales $889.000K Miss $1.450M Estimate
Benzinga · 10h ago
IceCure Medical Posts Higher H1 2026 Revenue but Wider Loss on Increased R&D Spend
TipRanks · 11h ago
IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
PR Newswire · 11h ago
IceCure Medical Announces Board Change and New Independent Director
TipRanks · 1d ago
Weekly Report: what happened at ICCM last week (0803-0807)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 5d ago
IceCure Medical Shareholders Approve Special Meeting Agenda on August 6, 2026
TipRanks · 6d ago
IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment
PR Newswire · 6d ago
Pediatrix Medical Group (MD) Beats Q2 Earnings and Revenue Estimates
NASDAQ · 08/04 11:25
Weekly Report: what happened at ICCM last week (0727-0731)?
Weekly Report · 08/03 10:14
IceCure Medical Announces That The Society Of Interventional Oncology Submitted A Petition To The National Comprehensive Cancer Network Breast Cancer Guidelines Panel To Include Percutaneous Cryoablation Without Surgical Excision As An Option For Breast Cancer
Benzinga · 07/29 12:30
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
PR Newswire · 07/27 12:32
Weekly Report: what happened at ICCM last week (0720-0724)?
Weekly Report · 07/27 10:18
Danaher (DHR) Q2 Earnings and Revenues Top Estimates
NASDAQ · 07/21 11:15
Weekly Report: what happened at ICCM last week (0713-0717)?
Weekly Report · 07/20 10:14
IceCure Medical expands U.S. commercial team for ProSense cryoablation
TipRanks · 07/14 12:40
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
PR Newswire · 07/14 12:32
Weekly Report: what happened at ICCM last week (0706-0710)?
Weekly Report · 07/13 10:16
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 07/08 21:05
IceCure Highlights Expanding Adoption Of ProSense Cryoablation In Brazil
NASDAQ · 07/06 13:03
More
Webull provides a variety of real-time ICCM stock news. You can receive the latest news about IceCure Medical Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About ICCM
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.